Most Popular

M & A Deals | M & A League Table | Real Assets | Sector Events |  Private Capital Conference

Netherlands: EQT Life Sciences takes €25m of Onward’s €40m private placement

Life Sciences Nick Herbert -
Euronext-listed Onward Medical, a medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injuries, has €40.6m by way of an accelerated bookbuild offering through a private placement with institutional investors. Some 13,520,254 new ordinary shares were issued at €3.00 per share, which brings the...

Singapore: Everest Medicines to acquire Hasten Biopharmaceuticals (SG) for US$250m

Distribution Nick Herbert -
Hong Kong-listed Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialisation of innovative therapeutics, has announced that its wholly-owned subsidiary, EverSea Medicines (Singapore), has entered into a Share Purchase Agreement with Hasten Biopharmaceuticals (Asia) to conditionally acquire the entire equity interest in its wholly-owned subsidiary, Hasten Biopharmaceuticals (SG) for US$250m. Everest Medicines, which has expertise and a track record both in China and with leading global pharmaceutical companies, is committed to becoming a leading global biopharmaceutical company in Asia. This acquisition extends the commercialisation capabilities...